BRISTOL MYERS SQUIBB CO

BMY · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $121.1B · 32,500 employees
170
SEC Filings
$58.56
Close 2026-06-29
5
Transcripts
32,500
Employees

Business Summary

Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases including cancer, cardiovascular conditions, immunology, and fibrosis. Key marketed products include Revlimid, Eliquis, Opdivo, Pomalyst, Orencia, Sprycel, Yervoy, Abraxane, and Empliciti. The company engages in extensive R&D, strategic alliances, licensing arrangements, and global manufacturing to bring therapies to patients worldwide.

Latest Stock Quote

BMY 2026-06-29 $58.56 O:$57.61 H:$58.58 L:$57.1669 Vol:11.8M VWAP:$58.1716
origin leaf: null

Next Earnings

expected 2026-10-29

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBMYdiscussed Artificial Intelligence
topic_mentionBMYdiscussed Artificial Intelligence
topic_mentionBMYdiscussed Blockchain & Crypto
topic_mentionBMYdiscussed Regulation
topic_mentionBMYdiscussed Healthcare & Bio
topic_mentionBMYdiscussed Artificial Intelligence
topic_mentionBMYdiscussed Blockchain & Crypto
topic_mentionBMYdiscussed Autonomous Vehicles
topic_mentionBMYdiscussed Supply Chain
topic_mentionBMYdiscussed Regulation
topic_mentionBMYdiscussed Sovereign & Government
topic_mentionBMYdiscussed Automotive
topic_mentionBMYdiscussed Healthcare & Bio
metricBMY EPSreported $6.05
topic_mentionBMYdiscussed Blockchain & Crypto
topic_mentionBMYdiscussed Regulation
topic_mentionBMYdiscussed Sovereign & Government
topic_mentionBMYdiscussed Automotive
topic_mentionBMYdiscussed Healthcare & Bio
metricBMY EPSreported $6.05

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-112025-12-310000014272-26-000004EDGAR86K words
2025-02-122024-12-310000014272-25-000039EDGAR—
2024-02-132023-12-310000014272-24-000044EDGAR—
2023-02-142022-12-310000014272-23-000046EDGAR—
2022-02-092021-12-310000014272-22-000051EDGAR—
2021-02-102020-12-310000014272-21-000066EDGAR—
2020-02-242019-12-310000014272-20-000082EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-07-302026-06-300000014272-26-000020EDGAR—
2026-04-302026-03-310000014272-26-000010EDGAR—
2025-10-302025-09-300000014272-25-000149EDGAR31K words
2025-07-312025-06-300000014272-25-000131EDGAR—
2025-04-242025-03-310000014272-25-000091EDGAR—
2024-10-312024-09-300000014272-24-000147EDGAR—
2024-07-262024-06-300000014272-24-000123EDGAR—
2024-04-252024-03-310000014272-24-000096EDGAR—
2023-10-262023-09-300000014272-23-000181EDGAR—
2023-07-272023-06-300000014272-23-000152EDGAR—
2023-04-272023-03-310000014272-23-000104EDGAR—
2022-10-262022-09-300000014272-22-000196EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-07-300000014272-26-000018EDGAR—
2026-05-080001140361-26-020036EDGAR—
2026-04-300000014272-26-000008EDGAR—
2026-02-050000014272-26-000002EDGAR17K words
2026-01-120001140361-26-000929EDGAR—
2025-11-180001140361-25-042607EDGAR—
2025-11-100001140361-25-041380EDGAR—
2025-11-030001140361-25-040066EDGAR—
2025-10-300000014272-25-000147EDGAR—
2025-07-310000014272-25-000129EDGAR—

170 total filings indexed. 141 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
— BMY Earnings Call Transcript
— BMY Earnings Call Transcript
—Q4 FY2025BMY Q4 FY2025 Earnings Call Transcript
—Q1 FY2026BMY Q1 FY2026 Earnings Call Transcript
—Q4 FY2025BMY Q4 FY2025 Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

oncology cardiovascular immunology fibrosis hematology

Company Identity

CIK0000014272
TickerBMY
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.bms.com
Listed1952-06-23

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9d38945c8fe92c159b9041340f4e04b9910a057f944d380903315262381b9ed6
parent: 0cff9062cdfd4bd6af7af6fea6dd1c697dadda95ab7d93acd6e5b30112f165b6
content hash: e1266761b929ac07f8e4b1393343e4de44af59b269baffabc85b4bf8e88c8bf1
signed: 2026-08-10T19:01:22.174Z
sources: 24 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up BMY using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on BMY, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/BMY (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.